Severe neurological damage associated with methotrexate therapy.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004569:Electroencephalography; D006801:Humans; D007263:Infusions, Parenteral; D007278:Injections, Spinal; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D009461:Neurologic Manifestations; D011605:Psychoses, Substance-Induced / Q000139:chemically induced; D013997:Time Factors
D008727:Methotrexate